Don't know what you are on about!!!
Your AUL is at least 40% down and looking like Administration is the next step. And your VRX is at least 30% down.
So its ironic that you come here to brag.
With CVN, we have close $140M in the bank; that is 10 times more than both your penny dreadful stocks (AUL and VRX).
- Forums
- ASX - By Stock
- CVN
- Out of favour sector
Out of favour sector, page-119
-
-
- There are more pages in this discussion • 22 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVN (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $304.1M |
Open | High | Low | Value | Volume |
16.5¢ | 17.0¢ | 16.5¢ | $74.25K | 443.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 266481 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 484699 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 266481 | 0.160 |
8 | 460540 | 0.155 |
9 | 554362 | 0.150 |
19 | 765692 | 0.145 |
12 | 557777 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 484699 | 8 |
0.175 | 947347 | 7 |
0.180 | 551225 | 9 |
0.185 | 877813 | 5 |
0.190 | 860388 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
CVN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online